Portland Global Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-37,729
| Closed | -$664K | – | 102 |
|
|
2017
Q3 | $664K | Sell |
37,729
-1,056
| -3% | -$18.6K | 0.25% | 57 |
|
|
2017
Q2 | $1.29M | Sell |
38,785
-200
| -0.5% | -$6.64K | 0.52% | 42 |
|
|
2017
Q1 | $1.25M | Buy |
38,985
+575
| +1% | +$18.5K | 0.52% | 42 |
|
|
2016
Q4 | $1.39M | Buy |
38,410
+2,525
| +7% | +$91.5K | 0.61% | 40 |
|
|
2016
Q3 | $1.65M | Sell |
35,885
-30
| -0.1% | -$1.38K | 0.73% | 33 |
|
|
2016
Q2 | $1.8M | Sell |
35,915
-385
| -1% | -$19.3K | 0.83% | 30 |
|
|
2016
Q1 | $1.94M | Sell |
36,300
-220
| -0.6% | -$11.8K | 0.93% | 27 |
|
|
2015
Q4 | $2.4M | Sell |
36,520
-990
| -3% | -$65K | 1.29% | 15 |
|
|
2015
Q3 | $2.12M | Sell |
37,510
-695
| -2% | -$39.2K | 1.25% | 15 |
|
|
2015
Q2 | $2.26M | Sell |
38,205
-200
| -0.5% | -$11.8K | 1.18% | 15 |
|
|
2015
Q1 | $2.39M | Sell |
38,405
-550
| -1% | -$34.3K | 1.24% | 13 |
|
|
2014
Q4 | $2.24M | Sell |
38,955
-335
| -0.9% | -$19.3K | 1.15% | 15 |
|
|
2014
Q3 | $2.11M | Sell |
39,290
-160
| -0.4% | -$8.6K | 1.09% | 17 |
|
|
2014
Q2 | $2.07M | Buy |
39,450
+1,730
| +5% | +$90.7K | 1.04% | 15 |
|
|
2014
Q1 | $1.99M | Sell |
37,720
-1,860
| -5% | -$98.3K | 1.17% | 14 |
|
|
2013
Q4 | $1.59M | Sell |
39,580
-145
| -0.4% | -$5.81K | 0.99% | 26 |
|
|
2013
Q3 | $1.5M | Sell |
39,725
-380
| -0.9% | -$14.4K | 1.01% | 23 |
|
|
2013
Q2 | $1.57M | Buy |
+40,105
| New | +$1.57M | 1.12% | 19 |
|